Answers are grounded in this paper and cite their sources.
Scoping review identifies associations between maternal microRNAs and birth weight, suggesting implications for neonatal health.
Maternal circulating microRNAs (miRNAs) are small non-coding RNA molecules that are capable of regulating gene expression and play a critical role in fetal growth. Emerging evidence suggests that alterations in maternal miRNA expression during pregnancy may influence infant birth weight, a key indicator of neonatal health and predictor of short- and long-term health outcomes. However, findings across studies are varied and inconsistent. This scoping review aims to identify and synthesize the current evidence on the association between maternal miRNAs during pregnancy and birth weight outcomes. Three databases, Scopus, Web of Science and MEDLINE-Pubmed, were searched for English articles from inception to October 2025. Of 284 records screened after duplicates, 33 full texts were assessed, and 25 studies met inclusion criteria for full-text review. This scoping review identified 11 miRNAs (miR-16-5p, miR-17, miR-18a, miR-20b-5p, miR-21, miR-92a, miR-127-3p, miR-143-3p, miR-181a-5p, miR-221-3p and miR-520a-5p) associated with birth weight in two or more studies, with lower levels of miR-18a consistently associated with high birth weight (HBW) and miR-181a-5p associated with low birth weight (LBW). This scoping review highlights the heterogeneity in associations between maternal circulating miRNAs and infant birth weight, underscoring key challenges that must be addressed before these miRNAs can be reliably used as biomarkers.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: